Oxadiazoles Have Butyrate-Specific Conditional Activity against Mycobacterium tuberculosis
about
Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery.Current challenges in drug discovery for tuberculosis.Hit Generation in TB Drug Discovery: From Genome to Granuloma.Synthesis and biological evaluation of aryl-oxadiazoles as inhibitors of Mycobacterium tuberculosis.
P2860
Oxadiazoles Have Butyrate-Specific Conditional Activity against Mycobacterium tuberculosis
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Oxadiazoles Have Butyrate-Spec ...... nst Mycobacterium tuberculosis
@en
type
label
Oxadiazoles Have Butyrate-Spec ...... nst Mycobacterium tuberculosis
@en
prefLabel
Oxadiazoles Have Butyrate-Spec ...... nst Mycobacterium tuberculosis
@en
P2093
P2860
P356
P1476
Oxadiazoles Have Butyrate-Spec ...... nst Mycobacterium tuberculosis
@en
P2093
Allen Casey
Isabel C Gonzalez Valcarcel
Juliane Ollinger
Julie V Early
Mai Ann Bailey
Maria Angeles Martinez-Grau
Megan Files
Michal Vieth
Tanya Parish
Torey Alling
P2860
P304
P356
10.1128/AAC.02896-15
P407
P577
2016-04-04T00:00:00Z